Advertisement

Eli Lilly Pitches Alzheimer Drug to the FDA, Aiming to Leapfrog Biogen

It's an exciting if turbulent, and rather cutthroat, time in the world of Alzheimer's drug research. In June, the FDA greenlit Biogen's...